How we will manage risks
We have planned to manage any potential clinical risks, including:
- Risk of drugs mismanagement / accidental overdose. This is possible, however, prescribed opioid substitution therapy is shown to reduce drugs overdose. People usually overdose due to use of multiple illicit drugs and alcohol. We will be reinforcing harm reduction advice and providing Naloxone.
- Risk of medication diversion. There is a possibility of an increase in illicit Methadone/Buprenorphine supply due to medication diversion. However, most long-term service users rely on their medication and are not likely to divert. We will manage this risk through education around drug safety and management
Keeping our patients informed
Spectrum prioritises harm prevention in substance misuse and we routinely discuss safe storage of medications, overdose risks and drug safety with our service users. We will be informing them of the changes outlined in this proposal, and:
- We will be providing service users with an information leaflet explaining the reasons for these changes, as well as online support and advice
- We will continue to provide community naloxone and will maximise our existing provision of safe storage boxes so that medication can be kept safely
- Spectrum staff will be providing telephone support and our bases will remain open for urgent care and (limited) face-to-face contact where necessary. We will continue to accept new referrals
Spectrum will also provide additional support for those who require complex care or are vulnerable due to other circumstances (e.g. in the case of homeless patients who cannot store medication safely). We will work closely with Team Leaders and Key Workers to identify these patients and work with them on a 1:1 basis.
For more information about the changes we’re proposing, please contact:
Dr. Helen Chidlow 07873 500 112 Helen.Chidlow@spectrum-cic.nhs.uk.
Andy Pearson 07802 875801 Andy.email@example.com